Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178361 | SCV000230427 | uncertain significance | not provided | 2015-04-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085557 | SCV000630850 | likely benign | Walker-Warburg congenital muscular dystrophy | 2024-10-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178361 | SCV001757158 | likely benign | not provided | 2021-04-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818438 | SCV002065975 | uncertain significance | not specified | 2017-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372094 | SCV002690746 | likely benign | Cardiovascular phenotype | 2022-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000178361 | SCV004139820 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FKRP: BP4, BP7 |